Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant

A.M. Martin; D. Nolan; S. Gaudieri; C. Almeida; I. James; E. Phillips; S. Mallal

doi:10.1073/pnas.0307067101

Back

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant

Journal article

Open access

Peer reviewed

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant

A.M. Martin, D. Nolan, S. Gaudieri, C. Almeida, I. James, E. Phillips and S. Mallal

Proceedings of the National Academy of Sciences, Vol.101(12), pp.4180-4185

2004

DOI: https://doi.org/10.1073/pnas.0307067101

Files and links (2)

pdf

predisposition_to_abacavir.pdfDownload View

Published (Version of Record) Open Access

url

Link to Published Version *Subscription may be requiredView

Abstract

Susceptibility to a clinically significant drug hypersensitivity syndrome associated with abacavir use seems to have a strong genetic component. We have previously shown that the presence of HLA-B*5701 strongly predicts abacavir hypersensitivity and have identified a potential susceptibility locus within a 300-kb region between the MEGT1 and C4A6 loci in the central MHC. We now report the results of fine recombinant genetic mapping in an expanded patient population of 248 consecutive, fully ascertained, abacavir-exposed individuals in the Western Australian HIV Cohort Study, in which 18 cases of definite abacavir hypersensitivity (7.3%) and 230 tolerant controls were identified. Haplotype mapping within patients with allelic markers of the 57.1 ancestral haplotype suggests a susceptibility locus within the 14-kb Hsp70 gene cluster. HLA-B*5701 was present in 94.4% of hypersensitive cases compared with 1.7% of controls (odds ratio, 960; P < 0.00001). A haplotypic nonsynonymous polymorphism of Hsp70-Hom (HspA1L, resulting from the substitution of residue M493T in the peptide-binding subunit) was found in combination with HLA-B*5701 in 94.4% of hypersensitive cases and 0.4% of controls (odds ratio, 3,893; P < 0.00001). Individuals with abacavir hypersensitivity demonstrated increased monocyte tumor necrosis factor expression in response to ex vivo abacavir stimulation, which was abrogated with CD8+ T cell depletion. These data indicate that the concurrence of HLA-B*5701 and Hsp70-Hom M493T alleles is necessary for the development of abacavir hypersensitivity, which is likely to be mediated by an HLA-B*5701-restricted immune response to abacavir.

Details

Title: Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant
Authors/Creators: A.M. Martin (Author/Creator) - Royal Perth Hospital
D. Nolan (Author/Creator) - Murdoch University
S. Gaudieri (Author/Creator) - Murdoch University
C. Almeida (Author/Creator) - Murdoch University
I. James (Author/Creator) - Murdoch University
E. Phillips (Author/Creator) - Sunnybrook Health Science Centre
S. Mallal (Author/Creator) - Murdoch University
Publication Details: Proceedings of the National Academy of Sciences, Vol.101(12), pp.4180-4185
Publisher: National Academy of Sciences
Identifiers: 991005545563707891
Copyright: © 2004 The National Academy of Sciences
Murdoch Affiliation: Centre for Clinical Immunology and Biomedical Statistics
Language: English
Resource Type: Journal article

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Metrics

258 File views/ downloads

80 Record Views

351 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.265 Dermatology - Skin Allergies; 1.265.1140 Drug Hypersensitivity
Web Of Science research areas: Immunology
ESI research areas: Immunology